Exelixis Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Exelixis Inc 's inventory turnover ratio sequentially decreased to 3.41 in the first quarter 2026, otherwise the ratio remained above the average, as EXEL's markets remain strong.Exelixis Inc 's average inventory processing period in the Apr 03 2026 quarter, has increased to 107 days, from 106 days, in the Jan 02 2026 quarter.

Within Healthcare sector 110 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 292 in the fourth quarter 2025, to 799.

EXEL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Exelixis Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EXEL Inventory Turnover Ratio	(Apr 03 2026) I. Quarter	(Jan 02 2026) IV. Quarter	(Oct 03 2025) III. Quarter	(Jul 04 2025) II. Quarter	(Apr 04 2025) I. Quarter
Y / Y Inventory Growth	7.05 %	-3.14 %	30.4 %	13.92 %	17.75 %
Y / Y Cost of Sales Growth	4.07 %	32.64 %	7.19 %	10.21 %	-9.8 %
Inventory Turnover Ratio (TTM)	3.41	3.44	3.15	3.31	3.34
EXEL's Total Ranking	# 799	# 292	# 533	# 196	# 810
Average inventory processing period	107	106	116	110	109
Seq. Inventory Growth	22.68 %	-20.86 %	16.69 %	-5.51 %	11.01 %
Seq. Cost of Sales Growth	-24.65 %	42.57 %	-4.6 %	1.55 %	-3.97 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 10
Healthcare Sector	# 111
Overall Market	# 799

Inventory Turnover Ratio Statistics
High	Average	Low
3.9	2.31	0.61
(Sep 27 2024)		(Sep 30 2014)

EXEL Company Profile >> Back to EXEL Efficiency Comparisons >> Compare EXEL Inventory Turnover Ratio to its Competitors

Financial Statements
Exelixis Inc 's Inventories	$ 27 Millions	Visit EXEL's Balance sheet
Exelixis Inc 's Cost of Revenues TTM	$ 84 Millions	Visit EXEL's Income Statement
What are EXEL's Sales?		Visit EXEL's Sales by Segment

Other Inventory Turnover Ratios
Exelixis Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EXEL's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EXEL's Competitors
Inventory Turnover Ratio for EXEL's Suppliers
Inventory Turnover Ratio for EXEL's Customers

You may also want to know
EXEL's Sales Growth Rates	EXEL's Pe Price to earnings ratio	EXEL's Receivables Turnover Ratio	EXEL's Stock Quote
EXEL's Net Income Growth Rates	EXEL's Ps Price to Sales ratio	EXEL's Sales per Employee	EXEL's Asset Turnover Ratio
EXEL's Net Margin	EXEL's Pb Price to Book ratio	EXEL's Financial Strength Ratios	EXEL's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Apr 03 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Apr 03 2026	Inventories at quarter ending Apr 03 2026
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions
Prophase Labs Inc	7.64	$ 2.361 Millions	$ 0 Millions
Bellevue Life Sciences Acquisition Corp	7.62	$ 1.986 Millions	$ 0 Millions
Lifemd Inc	7.60	$ 24.000 Millions	$ 3 Millions
Charles River Laboratories International inc	7.56	$ 2,346.239 Millions	$ 310 Millions
Adaptive Biotechnologies Corporation	7.43	$ 73.088 Millions	$ 10 Millions
Puma Biotechnology Inc	7.19	$ 58.025 Millions	$ 8 Millions
Fonar Corporation	7.06	$ 19.685 Millions	$ 3 Millions
Carlisle Companies Incorporated	6.71	$ 3,206.100 Millions	$ 478 Millions
Hims and Hers Health Inc	6.58	$ 670.000 Millions	$ 102 Millions
Vanda Pharmaceuticals Inc	6.54	$ 12.682 Millions	$ 2 Millions
Twist Bioscience Corporation	6.50	$ 196.251 Millions	$ 30 Millions
Phathom Pharmaceuticals Inc	6.48	$ 30.871 Millions	$ 5 Millions
Precision Optics Corporation Inc	6.47	$ 24.932 Millions	$ 4 Millions
Nuo Therapeutics Inc	6.42	$ 1.331 Millions	$ 0 Millions
Collegium Pharmaceutical Inc	6.41	$ 256.071 Millions	$ 40 Millions
Veracyte Inc	6.05	$ 132.000 Millions	$ 22 Millions
Kewaunee Scientific Corporation	5.98	$ 200.155 Millions	$ 33 Millions
Adm Tronics Unlimited Inc	5.93	$ 1.992 Millions	$ 0 Millions
Align Technology inc	5.81	$ 1,327.000 Millions	$ 228 Millions
Transmedics Group Inc	5.71	$ 260.151 Millions	$ 46 Millions
Opko Health Inc	5.69	$ 372.048 Millions	$ 65 Millions
Avantor Inc	5.55	$ 4,447.000 Millions	$ 801 Millions

Date modified: 2026-08-29T17:16:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.